Robert Brookins - Alexium International Insider

Alexium International Group Limited -- Australia Stock  

AUD 0.32  0.01  3.23%

VP of RandD

Dr. Robert Brookins serves as Vice President Research Development of Alexium International Group Ltd. Dr. Brookins has broad experience in organic synthesis and materials chemistry. He received his PhD from the University of Florida under research advisor John R. Reynolds
  VP Since 2015  Ph.D    
61 8 9384 3160
Brookins? graduate work was in the synthesis and characterization of conjugated polyelectrolytes and polymers. Upon completion of his PhD, he worked at the Air Force Research Laboratory at Tyndall AFB where he developed decontamination methods for chemical and biological threats and novel synthetic routes for functional surfaces.

Management Efficiency

The company has return on total asset (ROA) of (60.85) % which means that it has lost $60.85 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (211.63) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 6.25 M in total debt. Alexium International Group Limited has Current Ratio of 0.86 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Entity Summary

Alexium International Group Limited develops and sells chemical solutions for military and commercial applications in Australia and the United States. Alexium International Group Limited (AJX) is traded on Australian Securities Exchange in Australia. It is located in Perth, WA and employs 11 people.

Did you try this?

Run Portfolio Optimization Now

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Hide  View All  NextLaunch Portfolio Optimization
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Alexium International Group Limited to your portfolio

Top Management

Alexium International Leadership Team
Craig SmithGander, Director
Jon Heard, Executive
Aaron Krech, CFO
Gavin Rezos, Chairman
Dirk Hyning, COO
Susan Thomas, Director
Craig Metz, Director
Claire Poll, Director
Karen Thurman, Director
Stephen Cheney, Director
Kevin Kye, Executive
Robert Brookins, VP, Ph.D
Nicholas Clark, CEO, CPA

Stock Performance

Alexium International Performance Indicators